Terms: = Prostate cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Prognosis
5 results:
1. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of GSTP1 and epigenetic regulators expression pattern in a population of Iranian patients with prostate cancer.
Mohammadi M; Irani S; Salahshourifar I; Hosseini J; Moradi A; Pouresmaeili F
Hum Antibodies; 2020; 28(4):327-334. PubMed ID: 32831196
[TBL] [Abstract] [Full Text] [Related]
3. DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.
Pistore C; Giannoni E; Colangelo T; Rizzo F; Magnani E; Muccillo L; Giurato G; Mancini M; Rizzo S; Riccardi M; Sahnane N; Del Vescovo V; Kishore K; Mandruzzato M; Macchi F; Pelizzola M; Denti MA; Furlan D; Weisz A; Colantuoni V; Chiarugi P; Bonapace IM
Oncogene; 2017 Oct; 36(40):5551-5566. PubMed ID: 28581528
[TBL] [Abstract] [Full Text] [Related]
4. Regulation of miR-200c and miR-141 by Methylation in prostate cancer.
Lynch SM; O'Neill KM; McKenna MM; Walsh CP; McKenna DJ
Prostate; 2016 Sep; 76(13):1146-59. PubMed ID: 27198154
[TBL] [Abstract] [Full Text] [Related]
5. Intravenous, intralesional and endolymphatic administration of lymphokines in human cancer.
Pulley MS; Nagendran V; Edwards JM; Dumonde DC
Lymphokine Res; 1986; 5 Suppl 1():S157-63. PubMed ID: 3784610
[TBL] [Abstract] [Full Text] [Related]
